• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Anal Chim Acta . Nanozymes featuring a mesoporous silica shell for rapid enrichment and ultrasensitive lateral flow immunoassay of influenza A

tetano

Editor, Senior Moderator
Anal Chim Acta


. 2025 Jan 15:1335:343474.
doi: 10.1016/j.aca.2024.343474. Epub 2024 Nov 23. Nanozymes featuring a mesoporous silica shell for rapid enrichment and ultrasensitive lateral flow immunoassay of influenza A

Jing Liang[SUP] 1 [/SUP], Xiaoxian Liu[SUP] 2 [/SUP], Zhenzhen Liu[SUP] 2 [/SUP], Xuanming Xu[SUP] 3 [/SUP], Yinuo Sun[SUP] 2 [/SUP], Yuan Chen[SUP] 3 [/SUP], Rui Xiao[SUP] 4 [/SUP], Yajie Wang[SUP] 5 [/SUP]



Affiliations
Abstract

Background: Respiratory illnesses stemming from influenza A viruses represent a significant worldwide health concern. There is an immediate need for a rapid and sensitive method to detect influenza A viruses early, without requiring extra equipment.
Results: Here, we established a lateral flow immunoassay (LFIA) for the detection of influenza A (Flu A) using a "three-in-one" multifunctional mesoporous Fe[SUB]3[/SUB]O[SUB]4[/SUB]@SiO[SUB]2[/SUB]@Pt nanozymes (Fe[SUB]3[/SUB]O[SUB]4[/SUB]@MSiO[SUB]2[/SUB]@Pt NZs) with excellent magnetic separation properties, colorimetric, and peroxidase-like (POD-like) activities. Effective enrichment of target Flu A in complex samples as well as greater loading of Pt particles by mesoporous structures with large specific surface area to enhance POD-like activity can significantly improve the detection sensitivity of the LFIA. After colorimetric amplification by Fe[SUB]3[/SUB]O[SUB]4[/SUB]@MSiO[SUB]2[/SUB]@Pt tags catalysis, the qualitative and quantitative results of detection for Flu A nucleoprotein (Flu A-NP) were 0.01 and 0.0089 ng mL[SUP]-1[/SUP], respectively. This indicated a sensitivity approximately 100 times greater than commercially available colloidal Au nanoparticle (AuNP)-based LFIA strips. For detection of inactivated H1N1 virus, quantification can be as low as 33 copies mL[SUP]-1[/SUP]. Moreover, it demonstrated high accuracy in pharyngeal swab sample simulation experiments.
Significance: Therefore, the proposed platform based on Fe[SUB]3[/SUB]O[SUB]4[/SUB]@MSiO[SUB]2[/SUB]@Pt NZs-LFIA offered a promising approach for point-of-care testing (POCT), enabling rapid and ultrasensitive diagnosis of Flu A.

Keywords: Colorimetric; Composite nanozymes; Influenza A; Lateral flow immunoassay; Mesoporous material.

 
Back
Top